iCAD’s Revenue Surges with AI and SaaS Focus

Q2 Revenue Growth and AI Expansion
iCAD Incorporated, a pioneer in AI-powered breast cancer detection, has reported a significant 21% increase in Q2 2024 revenue, achieving $5 million compared to the same period last year. This growth is attributed to their strategic shift towards a Software as a Service (SaaS) platform, highlighted by the launch of the ProFound Cloud Platform on the Google Cloud Platform. This transition aims to boost both profitability and cash flow.